ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
about
A targeted genome association study examining transient receptor potential ion channels, acetylcholine receptors, and adrenergic receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.Dysregulation of Protein Kinase Gene Expression in NK Cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients.Association of biomarkers with health-related quality of life and history of stressors in myalgic encephalomyelitis/chronic fatigue syndrome patients.Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels.A Pyrazolo[3,4-d]pyrimidine compound inhibits Fyn phosphorylation and induces apoptosis in natural killer cell leukemia.Intermittent and graded exercise effects on NK cell degranulation markers LAMP-1/LAMP-2 and CD8+CD38+ in chronic fatigue syndrome/myalgic encephalomyelitis.The X-linked juvenile retinoschisis protein retinoschisin is a novel regulator of mitogen-activated protein kinase signalling and apoptosis in the retina.Effects of total flavonoids of sea buckthorn ( Hippophae rhamnoides L.) on cytotoxicity of NK92-MI cells.Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation.Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients
P2860
Q36190203-C1F268D9-C429-4452-887F-5A4ED4DB9820Q37213332-475A39D2-7A74-4F9A-AD28-2FEB7AA4DB78Q37221100-1E1F775E-3C7B-4EB1-B3C7-3402EF712D32Q37567560-F64717A9-A43E-470E-BD12-A141138A4EB2Q37662204-CDB58511-886F-4A0D-A130-CFA3A984A1F9Q37699630-2E3243C8-411F-4224-BD25-678CEC0DFF9EQ39084685-BDE40A60-FA42-4940-BEBB-F50450863D7AQ47672762-4D6AD787-E1E3-43AB-81B7-041BFDEB5B3CQ51733779-AC87897F-FB44-4AA3-B46F-730AB3D4BD07Q58782400-EB5EAB19-6FEA-4327-AA37-0006D940E0AA
P2860
ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
ERK1/2, MEK1/2 and p38 downstr ...... ic Encephalomyelitis patients.
@en
type
label
ERK1/2, MEK1/2 and p38 downstr ...... ic Encephalomyelitis patients.
@en
prefLabel
ERK1/2, MEK1/2 and p38 downstr ...... ic Encephalomyelitis patients.
@en
P2860
P1476
ERK1/2, MEK1/2 and p38 downstr ...... ic Encephalomyelitis patients.
@en
P2093
Donald Staines
Teilah Kathryn Huth
P2860
P2888
P356
10.1186/S12967-016-0859-Z
P577
2016-04-21T00:00:00Z